• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖清除率测量与肝血流量

Galactose clearance measurements and liver blood flow.

作者信息

Keiding S

机构信息

Medical Department A, Rigshospitalet, Copenhagen, Denmark.

出版信息

Gastroenterology. 1988 Feb;94(2):477-81. doi: 10.1016/0016-5085(88)90440-4.

DOI:10.1016/0016-5085(88)90440-4
PMID:3335319
Abstract

Galactose clearance, measured during low galactose infusion and calculated as infusion rate divided by peripheral galactose concentration (systemic clearance), has been proposed as a measure of liver blood flow. This requires nearly complete hepatic extraction as well as negligible extrahepatic elimination. The purpose of the study was to examine if these assumptions are fulfilled in subjects with no liver disease, and to compare the galactose clearance measurement with an independent measurement of liver blood flow. Liver blood flow was measured in 6 subjects by means of a constant indocyanine green infusion, indocyanine green concentration measurements in a peripheral artery and a hepatic vein, and calculation according to Fick's principle. The mean (+/- SEM) blood flow rate was 1.2 +/- 0.1 L/min. Galactose was given at a constant infusion rate of 142 +/- 10 mumol/min, and steady-state concentrations were measured in the peripheral artery (A) and the hepatic vein (V). The hepatic extraction fraction [(A - V)/A] was 0.91 +/- 0.03. The hepatic galactose elimination rate [(A - V) X flow] was 101 +/- 12 mumol/min; this is about two-thirds of the total elimination rate (viz., infusion rate). Urinary excretion was negligible. This indicates an extrahepatic galactose elimination of approximately 41 mumol/min. Systemic galactose clearance, calculated as mentioned above, was 1.5 +/- 0.1 L blood/min. It was significantly higher than the liver blood flow in each subject (paired t-test, each p less than 0.02), on average 133% of the flow. Thus the systemic galactose clearance value overestimates liver blood flow, probably due to a small, but in this context quantitatively important, extrahepatic galactose elimination.

摘要

在低剂量半乳糖输注期间测量并通过输注速率除以外周半乳糖浓度计算得出的半乳糖清除率(全身清除率),已被提议作为肝血流量的一种测量方法。这需要几乎完全的肝脏摄取以及可忽略不计的肝外消除。本研究的目的是检验这些假设在无肝脏疾病的受试者中是否成立,并将半乳糖清除率测量值与肝血流量的独立测量值进行比较。通过持续输注吲哚菁绿、测量外周动脉和肝静脉中的吲哚菁绿浓度,并根据菲克原理进行计算,对6名受试者的肝血流量进行了测量。平均(±标准误)血流速率为1.2±0.1升/分钟。以142±10微摩尔/分钟的恒定输注速率给予半乳糖,并测量外周动脉(A)和肝静脉(V)中的稳态浓度。肝脏摄取分数[(A - V)/A]为0.91±0.03。肝脏半乳糖消除率[(A - V)×血流量]为101±12微摩尔/分钟;这约为总消除率(即输注速率)的三分之二。尿排泄可忽略不计。这表明肝外半乳糖消除约为41微摩尔/分钟。如上所述计算得出的全身半乳糖清除率为1.5±0.1升血液/分钟。在每个受试者中,它均显著高于肝血流量(配对t检验,每个p值均小于0.02),平均为血流量的133%。因此,全身半乳糖清除率值高估了肝血流量,这可能是由于存在少量但在此情况下数量上很重要的肝外半乳糖消除。

相似文献

1
Galactose clearance measurements and liver blood flow.半乳糖清除率测量与肝血流量
Gastroenterology. 1988 Feb;94(2):477-81. doi: 10.1016/0016-5085(88)90440-4.
2
Hepatic galactose elimination kinetics in the intact pig.完整猪肝脏中半乳糖清除动力学
Scand J Clin Lab Invest. 1982 May;42(3):253-9.
3
Splanchnic galactose uptake in patients with cirrhosis during continuous infusion.肝硬化患者在持续输注过程中内脏对半乳糖的摄取
Clin Physiol. 1983 Apr;3(2):179-85. doi: 10.1111/j.1475-097x.1983.tb00689.x.
4
The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.在实质肝疾病患者中,半乳糖类似物 2-18F-氟-2-脱氧-D-半乳糖的团集常数增加。
J Nucl Med. 2014 Apr;55(4):590-4. doi: 10.2967/jnumed.113.125559. Epub 2014 Mar 3.
5
Sorbitol as a test substance for measurement of liver plasma flow in humans.
Hepatology. 1998 Jul;28(1):50-6. doi: 10.1002/hep.510280109.
6
Hepatic, renal, and total body galactose elimination in the pig.猪肝脏、肾脏及全身的半乳糖清除率
Am J Physiol. 1993 Jul;265(1 Pt 1):G9-14. doi: 10.1152/ajpgi.1993.265.1.G9.
7
Volumetric and functional liver blood flow are both increased in the human transplanted liver.
J Hepatol. 1993 Feb;17(2):204-7. doi: 10.1016/s0168-8278(05)80039-x.
8
Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.静脉推注和持续输注后完整猪体内吲哚菁绿的血浆清除:分光光度法和高压液相色谱法用于浓度分析的比较
Hepatology. 1993 Dec;18(6):1504-15.
9
Bedside micro-method for measuring effective hepatic blood flow, with use of first-order galactose clearance pharmacokinetics.采用一级半乳糖清除药代动力学的床边微量法测量有效肝血流量。
Clin Chem. 1985 Sep;31(9):1557-9.
10
Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.
Gastroenterology. 1988 Sep;95(3):749-59. doi: 10.1016/s0016-5085(88)80024-6.

引用本文的文献

1
Quantitative PET of liver functions.肝脏功能的定量正电子发射断层扫描
Am J Nucl Med Mol Imaging. 2018 Apr 25;8(2):73-85. eCollection 2018.
2
Hypoxic Hepatitis: A Review and Clinical Update.缺氧性肝炎:综述与临床进展
J Clin Transl Hepatol. 2016 Sep 28;4(3):263-268. doi: 10.14218/JCTH.2016.00022. Epub 2016 Sep 7.
3
Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations.肝硬化患者的剂量调整:对药物不良反应和住院的影响。
Eur J Clin Pharmacol. 2013 Aug;69(8):1565-73. doi: 10.1007/s00228-013-1502-z. Epub 2013 Apr 16.
4
Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy.右半肝切除术后活体供肝肝再生相关的功能元件。
Liver Transpl. 2013 Mar;19(3):292-304. doi: 10.1002/lt.23592.
5
Bringing physiology into PET of the liver.将生理学纳入肝脏 PET。
J Nucl Med. 2012 Mar;53(3):425-33. doi: 10.2967/jnumed.111.100214. Epub 2012 Feb 9.
6
Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.使用 2-[18F]氟-2-脱氧-D-半乳糖 PET/CT 对人体肝脏半乳糖代谢进行定量研究。
J Nucl Med. 2011 Oct;52(10):1566-72. doi: 10.2967/jnumed.111.092924. Epub 2011 Aug 29.
7
Determination of hepatic galactose elimination capacity using 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model.使用2-[¹⁸F]氟-2-脱氧-D-半乳糖PET/CT测定肝脏半乳糖清除能力:该方法在正常猪肝模型中的可重复性及代谢异质性
Scand J Gastroenterol. 2011 Jan;46(1):98-103. doi: 10.3109/00365521.2010.510574. Epub 2010 Aug 9.
8
Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.低氧性肝炎——流行病学、病理生理学和临床管理。
Wien Klin Wochenschr. 2010 Mar;122(5-6):129-39. doi: 10.1007/s00508-010-1357-6.
9
Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.半乳糖的肝脏摄取和代谢可通过2-[18F]氟-2-脱氧半乳糖正电子发射断层扫描在体内进行定量分析。
Am J Physiol Gastrointest Liver Physiol. 2008 Jul;295(1):G27-G36. doi: 10.1152/ajpgi.00004.2008. Epub 2008 May 15.
10
Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.婴儿肝脏和肾脏全身清除途径的个体发生:第一部分。
Clin Pharmacokinet. 2002;41(12):959-98. doi: 10.2165/00003088-200241120-00003.